Abstract
The oral route is considered to be the most preferred route for administration of drugs for systemic effect, but the oral route is not suitable to the administration of drug for lower gastrointestinal (GI) diseases, this happened due to their release at upper GI tract (stomach, small intestine), which further minimizes the accessibility of drugs at the lower GI tract. Colorectal cancer (CCR) is the third most common cancer worldwide in men and women, the second largest cause of death related to cancer, and the main cause of death in gastrointestinal cancer. In this review, we describe the stages, diagnosis, sign & symptoms, risk factors and drug therapy of some antibodies used to treat the colon cancer. Presently, the monoclonal antibodies most frequently used in the treatment of colorectal tumours are bevacizumab, cetuximab, panitumumab, and ramucirumab.zgr
Keywords
Colonoscopy, Biopsy, Blood Test, Colon Cancer, Colorectal Tumours
How to Cite:
Bharti Vrushali Avinash, Bhujbal Sanchita Dattatray, Attar Saba Had Mehrin Arif, Prof. Ashok Chopane , A REVIEW ON COLON TARGETED DRUG DELIVERY SYSTEM , Volume 10 , Issue 12, December 2025, EPRA International Journal of Research & Development (IJRD), Pages: 181 - 196 ,